TNSN08537A1 - Precurseurs de medicaments du type peneme - Google Patents
Precurseurs de medicaments du type penemeInfo
- Publication number
- TNSN08537A1 TNSN08537A1 TNP2008000537A TNSN08537A TNSN08537A1 TN SN08537 A1 TNSN08537 A1 TN SN08537A1 TN P2008000537 A TNP2008000537 A TN P2008000537A TN SN08537 A TNSN08537 A TN SN08537A TN SN08537 A1 TNSN08537 A1 TN SN08537A1
- Authority
- TN
- Tunisia
- Prior art keywords
- type
- peneme
- drug precursors
- precursors
- drug
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000002243 precursor Substances 0.000 title abstract 2
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 title 1
- FLSUCZWOEMTFAQ-PRBGKLEPSA-N (5r,6s)-6-[(1r)-1-hydroxyethyl]-7-oxo-3-[(1r,3s)-1-oxothiolan-3-yl]sulfanyl-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound S([C@@H]1[C@H](C(N1C=1C(O)=O)=O)[C@H](O)C)C=1S[C@H]1CC[S@@](=O)C1 FLSUCZWOEMTFAQ-PRBGKLEPSA-N 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229950000153 sulopenem Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Des précurseurs, doués de biodisponibilité orale, de médicaments du type sulopénème, par exemple (I) et leurs produits de solvatation et hydrates, leur préparation, leur formulation, et l'utilisation pour traiter et prévenir une infection chez des mammifères tels que les êtres humains. Cet abrégé ne limite pas l'invention.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80600006P | 2006-06-28 | 2006-06-28 | |
US91158707P | 2007-04-13 | 2007-04-13 | |
PCT/IB2007/001843 WO2008001212A2 (fr) | 2006-06-28 | 2007-06-18 | Prodrogues de pénem |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN08537A1 true TNSN08537A1 (fr) | 2010-04-14 |
Family
ID=38463109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2008000537A TNSN08537A1 (fr) | 2006-06-28 | 2008-12-26 | Precurseurs de medicaments du type peneme |
Country Status (29)
Country | Link |
---|---|
US (2) | US7795243B2 (fr) |
EP (1) | EP2044085B1 (fr) |
JP (2) | JP4397435B2 (fr) |
KR (1) | KR101060448B1 (fr) |
AP (1) | AP2008004705A0 (fr) |
AR (1) | AR061646A1 (fr) |
AT (1) | ATE493419T1 (fr) |
AU (1) | AU2007263519B2 (fr) |
BR (1) | BRPI0712740A2 (fr) |
CA (1) | CA2655485C (fr) |
CL (1) | CL2007001910A1 (fr) |
CR (1) | CR10467A (fr) |
DE (1) | DE602007011622D1 (fr) |
DK (1) | DK2044085T3 (fr) |
EA (1) | EA200870584A1 (fr) |
EC (1) | ECSP088947A (fr) |
GT (1) | GT200700050A (fr) |
HK (1) | HK1134928A1 (fr) |
IL (1) | IL195383A0 (fr) |
MA (1) | MA30568B1 (fr) |
MX (1) | MX2009000116A (fr) |
NL (1) | NL2000715C2 (fr) |
NO (1) | NO20090392L (fr) |
PE (1) | PE20080940A1 (fr) |
SV (1) | SV2008003139A (fr) |
TN (1) | TNSN08537A1 (fr) |
TW (1) | TW200816999A (fr) |
UY (1) | UY30439A1 (fr) |
WO (1) | WO2008001212A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20080940A1 (es) * | 2006-06-28 | 2008-07-09 | Pfizer Prod Inc | Profarmacos de penem |
US20080125408A1 (en) * | 2006-11-14 | 2008-05-29 | Pfizer Inc | Penem prodrug |
WO2009108704A1 (fr) * | 2008-02-25 | 2009-09-03 | Semafore Pharmaceuticals, Inc. | Combinaison de promédicaments inhibiteurs de pi-3 kinase o-alkylés |
KR100916052B1 (ko) | 2009-02-24 | 2009-09-08 | 코오롱건설주식회사 | 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브 |
CA2768877A1 (fr) * | 2009-08-10 | 2011-02-17 | Bellus Health Inc. | Procedes, composes, et compositions pour administrer de l'acide 1,3-propane disulfonique |
US11554112B2 (en) * | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
EA202192193A1 (ru) | 2019-02-13 | 2021-11-09 | Итерум Терапьютикс Интернэшнл Лимитед | Комбинации бета-лактамных соединений и пробенецида и их применения |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4619924A (en) * | 1984-05-18 | 1986-10-28 | Pfizer Inc. | 2-alkylthiopenem derivatives |
US4870170A (en) * | 1985-10-17 | 1989-09-26 | Pfizer Inc. | Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics |
WO1988008845A1 (fr) * | 1987-05-11 | 1988-11-17 | Pfizer Inc. | Acides diastereomeres 5r,6s-6-(1r-hydroxyethyle)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxyliques |
GB8713515D0 (en) | 1987-06-10 | 1987-07-15 | Erba Farmitalia | Methoxymethyl compounds |
US4874877A (en) * | 1988-04-19 | 1989-10-17 | Pfizer Inc. | Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs |
US5703068A (en) | 1990-08-20 | 1997-12-30 | Suntory Limited | Penem compounds |
EP0544905B1 (fr) | 1990-08-20 | 1998-10-14 | Suntory Limited | Composes antibacteriens de penem |
WO2004067532A1 (fr) | 2003-01-31 | 2004-08-12 | Meiji Seika Kaisha, Ltd. | Nouveaux dérivés de carbapenem |
PE20080940A1 (es) * | 2006-06-28 | 2008-07-09 | Pfizer Prod Inc | Profarmacos de penem |
WO2008008845A2 (fr) * | 2006-07-11 | 2008-01-17 | Microchips, Inc. | Dispositif multi-réservoirs à pompe pour dialyse, biodétection ou administration de substances |
US20080125408A1 (en) * | 2006-11-14 | 2008-05-29 | Pfizer Inc | Penem prodrug |
-
2007
- 2007-06-14 PE PE2007000755A patent/PE20080940A1/es not_active Application Discontinuation
- 2007-06-18 AT AT07734929T patent/ATE493419T1/de not_active IP Right Cessation
- 2007-06-18 KR KR1020087031533A patent/KR101060448B1/ko not_active IP Right Cessation
- 2007-06-18 CA CA2655485A patent/CA2655485C/fr not_active Expired - Fee Related
- 2007-06-18 EP EP07734929A patent/EP2044085B1/fr active Active
- 2007-06-18 AU AU2007263519A patent/AU2007263519B2/en not_active Ceased
- 2007-06-18 BR BRPI0712740-5A patent/BRPI0712740A2/pt not_active IP Right Cessation
- 2007-06-18 DK DK07734929.8T patent/DK2044085T3/da active
- 2007-06-18 WO PCT/IB2007/001843 patent/WO2008001212A2/fr active Application Filing
- 2007-06-18 MX MX2009000116A patent/MX2009000116A/es active IP Right Grant
- 2007-06-18 JP JP2009517474A patent/JP4397435B2/ja not_active Expired - Fee Related
- 2007-06-18 AP AP2008004705A patent/AP2008004705A0/xx unknown
- 2007-06-18 DE DE602007011622T patent/DE602007011622D1/de active Active
- 2007-06-18 EA EA200870584A patent/EA200870584A1/ru unknown
- 2007-06-19 NL NL2000715A patent/NL2000715C2/nl not_active IP Right Cessation
- 2007-06-25 GT GT200700050A patent/GT200700050A/es unknown
- 2007-06-26 UY UY30439A patent/UY30439A1/es not_active Application Discontinuation
- 2007-06-26 AR ARP070102825A patent/AR061646A1/es not_active Application Discontinuation
- 2007-06-27 TW TW096123288A patent/TW200816999A/zh unknown
- 2007-06-28 CL CL2007001910A patent/CL2007001910A1/es unknown
- 2007-06-28 US US11/769,849 patent/US7795243B2/en active Active
-
2008
- 2008-06-30 US US12/164,818 patent/US7795244B2/en active Active
- 2008-11-19 IL IL195383A patent/IL195383A0/en unknown
- 2008-11-27 CR CR10467A patent/CR10467A/es not_active Application Discontinuation
- 2008-12-08 EC EC2008008947A patent/ECSP088947A/es unknown
- 2008-12-23 SV SV2008003139A patent/SV2008003139A/es not_active Application Discontinuation
- 2008-12-26 TN TNP2008000537A patent/TNSN08537A1/fr unknown
- 2008-12-26 MA MA31512A patent/MA30568B1/fr unknown
-
2009
- 2009-01-27 NO NO20090392A patent/NO20090392L/no not_active Application Discontinuation
- 2009-09-04 JP JP2009204301A patent/JP5152527B2/ja active Active
- 2009-12-23 HK HK09112093.2A patent/HK1134928A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN08537A1 (fr) | Precurseurs de medicaments du type peneme | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
CR20220675A (es) | Análogos de nucleósido de 1´- ciano y usos de los mismos | |
SE0102315D0 (sv) | Compounds | |
MXPA04002167A (es) | Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
HK1085667A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
EA201270738A1 (ru) | Модуляторы фармакокинетических свойств лекарственных средств | |
UA95715C2 (ru) | Фосфадиазиновые производные, фармацевтическая композиция и их применение | |
MA29213B1 (fr) | Quinolones a substitution macrolones - amino | |
WO2007128086A3 (fr) | Nouvel inhibiteur de la réplication virale | |
ES2186550A1 (es) | Nuevos derivados de oxazolidinonas como antibacterianos. | |
CR20230100A (es) | Compuestos fosfolípidos y usos de los mismos | |
BR0315139A (pt) | Agentes antibacterianos de tetraidroquinolina tricìclica | |
DE60001586D1 (de) | Diphenyl-piperidin derivate | |
ATE360428T1 (de) | Analgetisches arzneimittel | |
IL157065A0 (en) | 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
EP1626731A4 (fr) | Compositions pharmaceutiques anti-inflammatoires permettant de reduire une inflammation et traitement ou prevention de la toxicite gastrique | |
AU4568400A (en) | Sphingomyelinase inhibitor | |
MA32128B1 (fr) | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artémisinine ou l'un de ses derives pour le traitement du paludisme severe | |
BRPI0713278A2 (pt) | agente profilÁtico ou terapÊutico para doenÇa viral | |
PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
NO20020914L (no) | Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav | |
MXPA02012232A (es) | Preparacion antipiretica concentrada de xilitol. | |
ATE277622T1 (de) | Arzneimittel enthaltend xenogene oligo- oder/und polyribonukleotide |